Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2025-12-24 @ 6:39 PM
NCT ID:
NCT05835557
Eligibility Criteria:
Inclusion Criteria:
* Male
* 18-40 years
* Actively performing endurance exercise (running or cycling) for at least 2 sessions (1 - 1.5h) per week
* Healthy (free from illnesses) and no musculoskeletal injuries for the past 6 months
* No history of cardiometabolic, vascular diseases or similar conditions (e.g., high blood pressure, peripheral vascular diseases, heart diseases, metabolic syndrome, diabetes, stroke, etc.).
* Pass the pre-participation health screening tests - Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and Australian Institute of Sport Blood Flow Restriction (AIS BFR) pre-screening questionnaire (no history of any risk factors).
* Achieve a maximum oxygen uptake (VO2max) of ≥40ml/kg/min during a maximal aerobic power cycling screening test.
* Non-smoker
* Drink alcohol less than 3 times each week and less than 3 drinks each time
Exclusion Criteria:
* Persons with any form of illnesses and/or musculoskeletal injuries for the past 6 months
* Any history of cardiometabolic, vascular diseases or similar conditions which may worsen with the use of blood flow restriction during exercise
* Fail the pre-participation health screening tests
* Below 40ml/kg/min VO2max during maximal aerobic power cycling test
* Smoker
* Consumption of alcohol beyond that stated in the inclusion criteria.
* History of asthma or taking medication for asthma.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT05835557
Study Brief:
Protocol Section:
NCT05835557